Aurinia Pharmaceuticals Inc. (AUPH) Free cash flow 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$135.4MFY2025 · since FY2018: -$51.7M → $135.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $135.4M | +207.0% |
| FY2024 | $44.1M | +229.0% |
| FY2023 | -$34.2M | +57.2% |
| FY2022 | -$79.8M | +49.5% |
| FY2021 | -$158.0M | -109.2% |
| FY2020 | -$75.5M | -18.6% |
| FY2019 | -$63.7M | -23.2% |
| FY2018 | -$51.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice